- Documentcutrone2005uploaded byMehak Lubana
- DocumentCRDDSuploaded byMehak Lubana
- DocumentCONTROLLED AND SUSTAINED RELEASE DOSAGEuploaded byMehak Lubana
- DocumentChapter 05uploaded byMehak Lubana
- Document21474221 Pharmaceutical Pre Formulationuploaded byMehak Lubana
- Document05-10-1uploaded byMehak Lubana
- Document21474221 Pharmaceutical Pre Formulationuploaded byMehak Lubana
- Document8. Pharmaceutics R17uploaded byMehak Lubana
- Document3- Sustained Release Dosage Formsuploaded byMehak Lubana
- Document1 SS Skin Cancer_chapter 1uploaded byMehak Lubana
- Document8935ea08a91b9a60357e72c3a415b71f-originaluploaded byMehak Lubana
- Document01 - Phosphate Bufferuploaded byMehak Lubana
- Document02_introductionuploaded byMehak Lubana
- Document15_M. Ph Drugs Regulatory Affairs.docuploaded byMehak Lubana
- Documentantipsychotics.pdfuploaded byMehak Lubana
- Documentantipsychotics.pdfuploaded byMehak Lubana
- Document8250d6b4-8992-413c-b3d9-7542b010c2a9.pdfuploaded byMehak Lubana
- Document8250d6b4-8992-413c-b3d9-7542b010c2a9.pdfuploaded byMehak Lubana
- Document1.physico_chem_properties.pptuploaded byMehak Lubana
- Document30facd77-3423-4935-8326-1ce26ec97dde.pdfuploaded byMehak Lubana
- Document30facd77-3423-4935-8326-1ce26ec97dde.pdfuploaded byMehak Lubana
- Document21.Mithun E.G. S.B.puranik and Nareshkumar Hasijauploaded byMehak Lubana
- Document6-Electromagnetic-Radiation-&-Spectrum-2010.pdfuploaded byMehak Lubana
- Document6-Electromagnetic-Radiation-&-Spectrum-2010.pdfuploaded byMehak Lubana
- Document201667174230Draft Prospectus _KPL.pdfuploaded byMehak Lubana
- DocumentFufnjuploaded byMehak Lubana
- Document03 Literature Reviewuploaded byMehak Lubana
- Document2415_pdfuploaded byMehak Lubana
- DocumentPptuploaded byMehak Lubana